CN105377241A - Api米格列醇的超快速崩解片剂配方 - Google Patents

Api米格列醇的超快速崩解片剂配方 Download PDF

Info

Publication number
CN105377241A
CN105377241A CN201480040954.3A CN201480040954A CN105377241A CN 105377241 A CN105377241 A CN 105377241A CN 201480040954 A CN201480040954 A CN 201480040954A CN 105377241 A CN105377241 A CN 105377241A
Authority
CN
China
Prior art keywords
tablet
miglitol
disintegration time
component
seconds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480040954.3A
Other languages
English (en)
Chinese (zh)
Inventor
T.莱希
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of CN105377241A publication Critical patent/CN105377241A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201480040954.3A 2013-07-19 2014-07-14 Api米格列醇的超快速崩解片剂配方 Pending CN105377241A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013150272 2013-07-19
JP2013-150272 2013-07-19
PCT/EP2014/065016 WO2015007676A1 (en) 2013-07-19 2014-07-14 Super quick disintegrating tablet formula for api miglitol

Publications (1)

Publication Number Publication Date
CN105377241A true CN105377241A (zh) 2016-03-02

Family

ID=51176393

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480040954.3A Pending CN105377241A (zh) 2013-07-19 2014-07-14 Api米格列醇的超快速崩解片剂配方

Country Status (5)

Country Link
EP (1) EP3021837A1 (ja)
JP (1) JP6506752B2 (ja)
CN (1) CN105377241A (ja)
HK (1) HK1221915A1 (ja)
WO (1) WO2015007676A1 (ja)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009071219A2 (en) * 2007-12-08 2009-06-11 Bayer Schering Pharma Aktiengesellschaft Oral dispersable tablet

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1615862A (zh) * 2003-11-10 2005-05-18 浙江医药股份有限公司新昌制药厂 一种治疗ⅱ型糖尿病的米格列醇口腔崩解片及其制备方法
JP5291324B2 (ja) 2007-11-01 2013-09-18 沢井製薬株式会社 口腔内崩壊錠
JP2009196940A (ja) * 2008-02-22 2009-09-03 Takada Seiyaku Kk 口腔内速崩壊錠及びその製造法
CN102600149B (zh) * 2012-02-02 2013-12-04 西藏易明西雅生物医药科技有限公司 一种治疗糖尿病的药物组合物
US20160136091A1 (en) * 2013-07-19 2016-05-19 Sanwa Kagaku Kenkyusho Co., Ltd. Orally Disintegrating Tablet

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009071219A2 (en) * 2007-12-08 2009-06-11 Bayer Schering Pharma Aktiengesellschaft Oral dispersable tablet

Also Published As

Publication number Publication date
EP3021837A1 (en) 2016-05-25
JP2016533383A (ja) 2016-10-27
JP6506752B2 (ja) 2019-04-24
WO2015007676A1 (en) 2015-01-22
HK1221915A1 (zh) 2017-06-16

Similar Documents

Publication Publication Date Title
US9655851B2 (en) Granular material for dosage forms
EP2210591B1 (en) Wet granulation tableting method using aqueous dispersion of low-substituted hydroxypropyl cellulose
EP2674149B1 (en) Method of preparing composite granule comprising low-substituted hydroxypropyl cellulose and rapid release preparation
CN1426297A (zh) 直接压制的固态剂量制剂
CN102665764A (zh) 可用作可再压实药物赋形剂的微晶纤维素和碳酸钙组合物
CN101612135A (zh) 一种用于直接压片的左乙拉西坦组合物及其制备方法
CN104039354A (zh) 基于固体分散物的配制物
WO2007066646A1 (ja) 高速直接打錠による錠剤の製造方法
JP6566450B2 (ja) 発泡組成物及びそれを製造する方法
CN102526748B (zh) 含有缬沙坦、氢氯噻嗪和苯磺酸氨氯地平的口服片剂
TW201124157A (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
CN102462663A (zh) 一种基于干法制粒的非洛地平药用组合物
GB2546513A (en) Process of preparing active pharmaceutical ingredient salts
CN105377241A (zh) Api米格列醇的超快速崩解片剂配方
CN110237073A (zh) 一种奥美沙坦酯氨氯地平片及其制备方法
CN104661652B (zh) 包含至少一种水溶性维生素e衍生物和至少一种亲水聚合物的储存稳定的无粉尘均质颗粒状配制剂
EP3256105B1 (en) Method of producing a granulated composition
CN115701992A (zh) 片剂及其制造方法
WO2009157564A1 (ja) セルロース組成物
EP3459530B1 (en) Burst drug release compositions
CN104546745A (zh) 醋酸阿比特龙的片剂组合物及其制备工艺
EP2575755A2 (en) Orodispersible tablets of erythritol and isomalt
JP6004882B2 (ja) 圧縮成形に用いるためのマンニトール賦形剤及びこれを含有する錠剤
CN104173296B (zh) 一种制备复合颗粒的方法及快速释放片剂
CN103989639A (zh) 一种盐酸苯海拉明颗粒及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1221915

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160302

WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1221915

Country of ref document: HK